-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905. Outcomes Research—Lymphoid Malignancies: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Michel Delforge1*, Marie-Christiane Vekemans, MD2*, Sébastien Anguille3,4*, Julien Depaus, MD5*, Nathalie Meuleman, PhD, MD6*, Ann Van de Velde, MD, PhD4,7*, Isabelle Vande Broek, MD, PhD8*, Danielle Strens9*, Sandra Van Hoorenbeeck10*, Evelien J Moorkens, PhD10*, Joris Diels11*, Francesca Ghilotti12*, Sander Dalhuisen13* and Sophie Vandervennet10*

1Universitaire Ziekenhuizen Leuven, Leuven, Belgium
2Cliniques Universitaires Saint-Luc, Brussels, Belgium
3Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
4Division of Hematology and Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium
5Department of Haematology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
6Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
7Heilig Hartziekenhuis, Lier, Belgium
8AZ Nikolaas, Haematology, Sint-Niklaas, Belgium
9Realidad bvba, Grimbergen, Belgium
10Janssen-Cilag NV, Beerse, Belgium
11Janssen Pharmaceutica NV, Beerse, Belgium
12Janssen-Cilag SpA, Cologno Monzese, Italy
13Janssen-Cilag BV, Breda, Netherlands

Abi Vijenthira, MD1, Xinzhi Li2*, Michael Crump3, Annette E. Hay4,5, Lois E. Shepherd6,7, Ralph Meyer8, Marina S. Djurfeldt6*, Bingshu E. Chen6* and Anca Prica, MD9

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
2Queen's University, Kingston, ON, Canada
3Division of Malignant Hematology and Hematology, Princess Margaret Hosp., Toronto, ON, Canada
4Department of Medicine, Queen's University, Kingston, ON, Canada
5Canadian Cancer Trials Group, Cancer Research Institute, Kingston, ON, Canada
6Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada
7Department of Pathology & Molecular Medicine, Queen's University, Kingston, ON, Canada
8Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada
9Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Anjana Mohan, M.Pharm1*, Keri Yang, PhD, MBA, MPH, MS2*, Sizhu Liu, MS2*, Randall Dick, FACSM3*, Boxiong Tang, MD, PhD2 and Asher Chanan-Khan, MBBS, MD4

1University of Houston, Houston, TX
2BeiGene, Ltd., Emeryville, CA
3IBM Watson Health, Cambridge, MA
4Mayo Clinic, Jacksonville, FL

Asher Chanan-Khan, MBBS, MD1, Keri Yang, PhD, MBA, MPH, MS2*, Tom Liu, MS2*, Todd Zimmerman, MD2*, Boxiong Tang, MD, PhD2 and Sikander Ailawadhi, MD1

1Mayo Clinic, Jacksonville, FL
2BeiGene, Ltd., Emeryville, CA

Keri Yang, PhD, MBA, MPH, MS1*, Sizhu Liu, MS1*, Boxiong Tang, MD, PhD1 and Asher Chanan-Khan, MBBS, MD2

1BeiGene, Ltd., Emeryville, CA
2Mayo Clinic, Jacksonville, FL

Jamie T. Ta, PharmD, MS1*, Stella Arndorfer, MSc2*, Cristina Julian1*, Mei Wu, PharmD1*, Dominic Lai, PharmD1* and Sheila Shapouri, PharmD, MS1*

1Genentech, Inc., South San Francisco, CA
2Genesis Research, Hoboken, NJ

Brian Warnecke, DO1*, Daniel Rosas, MD1, Alexandra Wehbe, MS2*, Qianqian Liu, PhD3*, Joel E Michalek, PhD4* and Adolfo Enrique Diaz Duque, MD, MSc1

1Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
2Wayne State School of Medicine, Detroit, MI
3Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
4Mays Cancer Center, University of Texas Health Science Center At San Antonio, San Antonio, TX

Elizabeth K. O'Donnell, MD1, Yael Shapiro1*, Omar Nadeem, MD2, Andrew J. Yee, MD3, Jacob P. Laubach, MD4, Andrew R. Branagan, MD, PhD3, Kenneth C. Anderson, MD5, Clifton C. Mo, MD2, Nikhil C. Munshi, MD, PhD6, Irene M. Ghobrial, MD7, Adam S. Sperling, MD, PhD8, Emerentia Agyemang, NP3*, Cynthia C. Harrington, NP3*, Jill N. Burke, NP3*, Paul G. Richardson, MD9, Noopur S. Raje, MD10 and Areej El-Jawahri, MD11

1Massachusetts General Hospital, Boston, MA
2The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Massachusetts General Hospital Cancer Center, Boston, MA
4The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA
5Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
6Dana-Farber Cancer Institute, Harvard Medical School, Boston
7Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
8Division of Hematology, Dana-Farber Cancer Institute, Boston, MA
9Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
10Division of Hematology and Oncology, Mass General Hospital Cancer Center, Boston, MA
11Blood and Marrow Transplant Program, Massachusetts General Hospital, Allston, MA

Jianming He1*, Heather Berringer2*, Bart Heeg3*, Tobias Kampfenkel4, Harikumaran R. Dwarakanathan5*, Stephen Johnston6*, João Mendes7*, Annette Lam1*, Sacheeta Bathija1* and Eric Mackay8*

1Janssen Global Services, Raritan, NJ
2Cytel, Inc., Vancouver, BC, Canada
3Ingress-Health, Rotterdam, Netherlands
4Janssen Research & Development, Leiden, Netherlands
5Mu Sigma Business Solutions, LLC, Bangalore, India
6Medical Device Epidemiology and Real-world Data Sciences, Johnson & Johnson, New Brunswick, NJ
7Jan-Cilag Farmacêutica, Porto Salvo, Portugal
8Cytel, Inc., Toronto, ON, Canada

Edward Paul Hackett, MS1*, Nirav N. Shah, MD2, Cecilia Hillard, PhD3*, Elizabeth Aughey1*, Rachel Cusatis2*, Aniko Szabo, PhD4* and Jennifer M Knight, MD MS5*

1School of Medicine, Medical College of Wisconsin, Wauwatosa, WI
2Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
3Department of Pharmacology and Toxicology and Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI
4Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
5Department of Psychiatry and Departments of Medicine and Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI

Megan B Sears-Smith, DO1*, Lillian Charboneau2*, Renju Raj, MD3 and R. Eric Heidel, PhD3*

1Internal Medicine, University of Tennessee Knoxville Graduate School of Medicine, Knoxville, TN
2University of Tennessee, Knoxville, TN
3University of Tennessee Knoxville Graduate School of Medicine, Knoxville, TN

Anthony R. Mato, MD1, Arliene Ravelo2*, Tu My To2*, Robert Schuldt2* and Juliana M.L. Biondo2*

1Memorial Sloan Kettering Cancer Center, New York, NY
2Genentech, Inc., South San Francisco, CA

Snegha Ananth, MD1, Ysaith Efren Orellana2*, Joel E Michalek, PhD3*, Qianqian Liu, PhD4* and Adolfo Enrique Diaz Duque, MD5

1Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
2Ohio University Heritage College of Osteopathic Medicine – Athens, Athens, OH
3Mays Cancer Center, University of Texas Health Science Center At San Antonio, San Antonio, TX
4Department of Epidemiology and Biostatistics, University of Texas Health at San Antonio, San Antonio, TX
5Hematology-Oncology Division, Assistant Professor, San Antonio, TX

Shlomzion Aumann, MD1*, Uria Tsubary2*, Sarah Israel, MD3*, Dina Ben Yehuda, MD1*, David Lavie, MD1*, Neta Goldschmidt4*, Vladimir Vainstein, MD1*, Diana Libster, MD1, Revital Saban, MD1*, Adir Shaulov, MD1*, Batia Avni, MD5*, Boaz Nachmias, MD, PhD1*, Sigal Grisariu, MD5*, Ora Paltiel, MD, MSc1,6, Moshe Gatt1 and Eran Zimran, MD1*

1Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
2Hadassah Medical School, Faculty of Medicine, Hebrew University, Jerusalem, Israel
3Depratment of Internal Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University, jerusalem, Israel
4Hadassah-Hebrew University Medical Center, Jerusalem, Israel
5Department of Bone Marrow Transplantation, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
6Braun School of Public Health, Faculty of Medicine, Hadassah- Hebrew University, Jerusalem, Israel

Tammy T. Hshieh, MD, MPH1,2,3*, Clark Dumontier, MD2,3,4*, Tim Jaung, MS1*, Nupur E. Bahl, BS1*, Emily S. Magnavita, MPH1*, Chelsea E. Hawley, PharmD, MPH4*, Lee Mozessohn, MD5,6, Richard M. Stone, MD3,7, Robert J. Soiffer, MD3,7,8, Jane Driver, MD, MPH3,9* and Gregory A. Abel, MD, MPH1,10

1Dana-Farber Cancer Institute, Boston, MA
2Brigham and Women's Hospital, Boston, MA
3Harvard Medical School, Boston, MA
4New England Geriatric Research Education and Clinical Center, Boston, MA
5Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
6University of Toronto, Toronto, ON, Canada
7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
8Department of Medicine, Brigham and Women’s Hospital, Boston, MA
9New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA
10Center for Bioethics, Harvard Medical School, Boston, MA

Gilbert Patrick Ancira, MD1, Joshua Romain, MD2, Jennifer Thornton, PhD2* and Christin Blair Destefano, MD2*

1Brooke Army Medical Center, San Antonio Uniformed Services Health Education Consortium, Diberville, TX
2David Grant USAF Medical Center, Travis AFB, CA

Jing Dong, PhD1, Zhuping Garacci, phD2*, Christopher Staffi Buradagunta, MS1*, Meera Mohan, MD1, Anita D'Souza, MD, MS3, Ashley Cunningham, MD4*, Siegfried Janz, MD, DSc1, Binod Dhakal, MBBS1 and Parameswaran Hari5

1Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI
3Division of Hematology Oncology, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
4Department of Pathology, Medical College of Wisconsin, Milwaukee, WI
5Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Natalia Neparidze, MD1,2, Rong Wang, PhD3*, Amer M. Zeidan, MD4,5, Nikolai Podoltsev, MD, PhD6,7, Rory M. Shallis, MD8, Xiaomei Ma, PhD2,9*, Amy J. Davidoff, PhD10,11* and Scott F. Huntington, MD, MPH2,7,12

1Section of Hematology, Yale University, New Haven, CT
2Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT
3Yale University School of Public Health, New Haven, CT
4Yale University and Yale Cancer Center, New Haven, CT
5Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, East Haven, CT
6Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Madison, CT
7Yale University School of Medicine, New Haven, CT
8Hematology, Yale University School of Medicine, New Haven, CT
9Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT
10Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT
11National Cancer Institute, NIH, Bethesda, MD
12Yale Cancer Center, Yale University School of Medicine, New Haven, CT

Ankit Kansagra, MD1, Eric Hansen, MS2*, Andrew J. Belli3*, Stefanie Goran2* and Ching-Kun Wang, MD2*

1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
2COTA, Inc., Boston, MA
3COTA, Inc., New York, NY

Othman Salim Akhtar, MD1, Chong Wang1*, Kristopher Attwood, PhD1*, Desi Carozza1*, Elizabeth R. Gage-Bouchard1*, Tunazzina Kaijar1*, Paola Ghione, MD1, Francisco J. Hernandez-Ilizaliturri, MD1, Tanya M. Wildes, MD, MSc2 and Pallawi Torka, MD3

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Cancer & Aging Research Group, St. Louis, MO
3Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Aurore Perrot1*, Thierry Facon2*, Shaji K Kumar, MD3, Torben Plesner, MD4, Robert Z. Orlowski5, Philippe Moreau, MD, PhD6*, Nizar J. Bahlis, MD7, Supratik Basu8*, Hareth Nahi9*, Cyrille Hulin10*, Hang Quach, FRACP, FRCPA11, Hartmut Goldschmidt12, Michael E. O'Dwyer, MD13, Chris P. Venner14, Katja Weisel15*, Joseph R. Mace16*, Noopur S. Raje, MD17, Mourad Tiab18*, Magaret Macro19*, Laurent Frenzel, MD, PhD20, Xavier Leleu, MD21, Kevin Liu22*, John Fastenau23*, Katharine S. Gries22*, Kai Fai Ho24*, Pankaj Mistry25*, Brenda Tromp26, Maria Delioukina27*, Jessica Vermeulen26 and Saad Z. Usmani, MD MBA FACP28

1CHU de Toulouse, IUCT-O, Université de Toulouse, Toulouse, France
2University of Lille, CHU Lille, Lille, France
3Mayo Clinic, Rochester, MN
4Vejle Hospital and University of Southern Denmark, Vejle, Denmark
5The University of Texas MD Anderson Cancer Center, Houston, TX
6University Hospital Hôtel-Dieu, Nantes, France
7Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
8Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom
9Karolinska University Hospital at Huddinge, Karolinska Institute, Stockholm, Sweden
10University Hospital, Hôpital Haut Lévêque, Pessac, France
11University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
12University Hospital Heidelberg and National Center of Tumor Diseases, Heidelberg, Germany
13National University of Ireland, Galway (NUIG), Galway, Ireland
14University of Alberta, Edmonton, Canada
15University Medical Center Hamburg-Eppendorf, Hamburg, Germany
16Florida Cancer Specialists, St. Petersburg, FL
17Massachusetts General Hospital Cancer Center, Boston, MA
18CHD Vendée, La Roche sur Yon, France
19CHU de Caen, Caen, France
20Assistance Publique–Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France
21CHU de Poitiers, Poitiers, France
22Janssen Global Services, Raritan, NJ
23Janssen Research & Development, Raritan, NJ
24STAT-TU, Inc, Toronto, ON, Canada
25Janssen Research & Development, High Wycombe, United Kingdom
26Janssen Research & Development, Leiden, Netherlands
27Janssen Research & Development, LLC, Spring House, PA
28Levine Cancer Institute/Atrium Health, Charlotte, NC

Kristin M. Zimmerman Savill, PhD1*, Andrew J Klink, PhD, MPH1*, Djibril Liassou, MSc1*, Dhruv Chopra, MS1*, Jalyna Laney, RN1* and Ajeet Gajra, MD, FACS1,2

1Cardinal Health Specialty Solutions, Dublin, OH
2SUNY Upstate Medical University, Jamesville, NY

Rebecca S Parker, MD1, Jemily Malvar, MS2*, Andrew Doan, MD1*, Paibel Aguayo-Hiraldo, MD3* and Chintan Parekh, MBBS4

1Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA
2Cancer and Blood Disease Institute, Children’s Hospital Los Angeles, Los Angeles, CA
3Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA
4Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA

Tanya Siddiqi, MD1, Ulrich Jaeger2, Olga Moshkovich, MPH3*, Julia Braverman, PhD4*, Fei Fei Liu, BSc, MBA4*, Sally Lanar, MA5*, Matthew Miera, BSc3*, Selam Shah, MPH3*, Jennifer Devlen, PhD3* and Gilles Salles, MD, PhD6

1City of Hope National Medical Center, Duarte, CA
2Medical University of Vienna, Vienna, Austria
3ICON plc, Gaithersburg, MD
4Bristol Myers Squibb, Princeton, NJ
5ICON plc, Lyon, France
6Memorial Sloan Kettering Cancer Center, New York, NY

Georgia Mills, MBBS1,2, Pietro R Di Ciaccio, MBBS FRACP FRCPA3,4, Catherine Tang, MBBS, BSc, FRACP, FRCPA5, Verity L Chadwick, MD6*, Kylie D Mason, MBBS, MD, FRACP, FRCPA, PhD7,8, Belinda Campbell, MBBS, MMed, FRANZCR9,10,11*, Mohamed Shanavas, MD FRACP FRCPA12,13, Kirk L Morris, MBBS FRACP FRCPA14, Matthew Greenwood, MBBS, FRACP, FRCPA15,16*, Giselle Kidson-Gerber, FRACP, FRCPA, MBBS17,18*, Renee Eslick, MBBS FRACP FRCPA19*, Xavier Badoux, MBBS FRACP FRCPA20,21*, Costas K. Yannakou, MBBS FRACP FRCPA22*, Shane A Gangatharan, MBBS, FRACP, FRCPA23,24 and Nada Hamad25,26,27

1Department of Haematology and Bone Marrow Transplant, St Vincents Hospital, Australia, Australia
2St Vincent's Clinical School Sydney, University of New South Wales, Sydney, NSW, Australia
3Department of Haematology, Sydney Adventist Hospital, Sydney, Australia
4St Vincent's Clinical School, University of New South Wales, Sydney, Australia
5Department of Haematology, Gosford Hospital, Gosford, Australia
6St Vincent's Hospital, Department of Haematology and Bone Marrow Transplant, Sydney, Australia
7Department of Medicine, University of Melbourne, Melbourne, Australia
8Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
9The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia
10Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
11Department of Clinical Pathology, University of Melbourne, Parkville, NSW, Australia
12Mater Hospital Brisbane, Brisbane, QLD, Australia
13Translational Research Institute, Blood Cancer Research Laboratory, Mater Research, University of Queensland, Brisbane, Australia
14Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
15Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
16Northern Clinical School, University of Sydney, Sydney, Australia
17Department of Haematology, Prince of Wales Hospital & The Royal Hospital for Women, Randwick, Australia
18Department of Medicine, University of New South Wales, Kensington, Australia
19Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia
20Department of Haematology, St. George Hospital, Sydney, NSW, Australia
21University of New South Wales, Kogarah, Australia
22Department of Molecular Oncology and Cancer Immunology, Epworth HealthCare, East Melbourne, VIC, Australia
23Fiona Stanley Hospital, Murdoch, Australia
24University of Western Australia, South Perth, Australia
25University of New South Wales, Sydney, Australia
26Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
27School of Medicine, University of Notre Dame, Sydney, NSW, Australia

P. Connor Johnson, MD1, Caron Jacobson, MD2, Alisha Yi1*, Areej El-Jawahri, MD3 and Matthew J. Frigault, MD4

1Massachusetts General Hospital, Boston, MA
2Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
3Blood and Marrow Transplant Program, Massachusetts General Hospital, Allston, MA
4HCTCT, Mass General Hospital Cancer Center, Boston, MA

Alaa Koleilat, PhD1*, Hongwei Tang, PhD1*, James B Smadbeck, PhD2*, Neeraj Sharma, PhD1*, Kathryn E. Pearce, MS1*, Eran Elhaik, PhD3*, Michael L. Baird, PhD4*, Yan Asmann, PhD5, Patricia Greipp, DO1, Jess F Peterson, MD1, Rhett P. Ketterling, MD1*, S. Vincent Rajkumar, MD6*, Shaji K Kumar, MD7 and Linda B Baughn, PhD1

1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
2Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester
3Department of Biology, Lund University, Lund, Sweden
4DNA Diagnostics Center, Fairfield, OH
5Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL
6Division of Hematology, Mayo Clinic, Rochester, MN
7Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Andres Gomez-De Leon, MD1, Ana Varela-Constantino, MD2*, Perla R. R. Colunga-Pedraza, MD1, Alexia Sánchez-Arteaga, MD1*, Valeria García-Zárate, MD1*, Nereida Méndez-Ramírez, MT1*, Eli de Jesús Fuentes-Chávez, MT1*, Elías Eugenio González López, MD1* and David Gomez-Almaguer, MD2

1Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González., Monterrey, Mexico
2Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, NL, Mexico

Geoffrey McInturf1*, Kimberly Younger2*, Courtney Sanchez3*, Charles Walde4*, Al-Ola Abdallah, MD5, Leyla Shune, MD6, Nausheen Ahmed, MD7*, Douglas W. Sborov, MD, MSc8, Amandeep Godara, MD8, Brian McClune, DO9*, Christian Sinclair4* and Ghulam Rehman Mohyuddin, MD8

1Kansas University medical center, Kansas City, KS
2Kansas University medical center, kansas city, KS
3Kansas University Medical Center, Kansas City, KS
4Kansas University Medical Center, Kansas City
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
6Division of Hematologic Malignancies and Cellular Therapeutics (HMCT), University of Kansas Medical Center, Kansas City, MO
7Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
8Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT
9Huntsman Cancer Center, Salt Lake City

Marcia Garnica, MD1,2*, Edvan De Queiroz Crusoe, MD, PhD3, Glaciano Ribeiro, MD4*, Rosane Bittencourt, MD5*, Roberto José Pessoa Magalhães, MD6*, Karla Richter Zanella, MD7*, Abrahão Elias Hallack Neto, MD, PhD8*, Juliana Lima, MD9*, Caroline Sola, MD10*, Emmanuella G Souza, MD11*, Andre Magalhaes, MD12*, Angelo Maiolino, MD13,14 and Vania Hungria15,16

1Internal Medicina Department, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
2Tranplant Unit, Complexo Hospitalar de Niterói (DASA - CHN), Niteroi, Brazil
3Hospital Universitário Professor Edgar Santos (HUPES), Universidade Federal da Bahia, Salvador, Brazil
4Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
5Hematology Division, University Hospital of the Federal University of Rio Grande do Sul, Porto Alegre, Brazil
6Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
7Clinica Viver- CEPHON, Florianópolis, BRA
8Division of Hematology and Oncology, Universidade Federal de Juiz de Fora, São Pedro, Brazil
9IHOC/Curitiba, Curitiba, BRA
10HC - UFPR, Curitiba, BRA
11Universidade Federal de Minas Gerais- Hospital Universitario, Belo Horizonte- MG, Brazil
12Clinica CEHON- Juazeiro, Juazeiro-BA, Brazil
13Universiadade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
14Américas Centro de Oncologia Integrado, Rio de Janeiro, Brazil
15Hematology, Santa Casa Medical School, São Paulo, Brazil
16São Germano Clinic, São Paulo, Brazil

Adriana Seber, MD, MS1, Mecneide Mendes Lins, MD, MMSc2*, Nicolle Queiroz Hazarbassanov, PhD, DVM3* and Maria Lucia De Martino Lee4*

1Hospital Samaritano, São Paulo, Brazil
2Pediatric Oncology Unit, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil
3Novartis Biosciences, Sao Paulo, Brazil
4Pediatric Hematology, Hospital BP Mirante, Sao Paulo, Brazil

Kathleen C Degen, MD1*, Vibha Ahuja, Ph.D.2*, Nolan L Metz, B.Sc.2*, Arezoo Ghaneie, MD3*, Aarti L Shevade, MD4*, Erik L. Zeger, MD5*, Tracey L Evans, M.D.4*, Zonera A. Ali, MD6* and U. Margaretha Wallon, Ph.D.7*

1Hematology - Oncology, Main Line Health Lankenau Medical Center, Wynnewood, PA
2Lankenau Institute for Medical Research, Wynnewood, PA
3Lankenau Hospital Medical Ctr., Wynnewood, PA
4Main Line Oncology Hematology Associates, Wynnewood, PA
5Main Line Oncology-Hematology Assoc., Wynnewood, PA
6Lankenau Hospital, Wynnewood, PA
7Lankenau Inst. Med. Res., Wynnewood, PA

Smith Giri, MD, MS1, Susan Bal, MD2, Kelly N. Godby, MD3*, Gayathri Ravi, MD4, Deanna Clark, MBA, MPH1*, Clare Ubersax, BS1*, Abigail Cooley, BS3*, Priscila White, BS3*, Sunil Rangarajan, MD5*, Grant R Williams, MD MSPH6* and Luciano J. Costa, MD, PhD7

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
3University of Alabama at Birmingham, Birmingham, AL
4O'Neal Cancer Center, University of Alabama Birmingham, Birmingham, AL
5University of Alabama, Birmingham
6Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
7University of Alabama at Birmingham, Vestavia, AL

Lindsay F Schwartz, MD1, Marcia M Tan, PhD2*, Julie S McCrae, PhD3*, Tiffany Burkhardt, PhD3*, Kirsten K. Ness, PT, PhD4* and Tara O Henderson, MD, MPH1*

1Section of Hematology, Oncology, and Stem Cell Transplantation, University of Chicago Comer Children's Hospital, Chicago, IL
2Department of Public Health Sciences, University of Chicago, Chicago, IL
3Chapin Hall at the University of Chicago, Chicago, IL
4Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN

Silvia Mangiacavalli, MD1*, Monica Galli, MD2*, Sara Pezzatti3*, Angelo Belotti, MD4*, Francesca Fazio5*, Magda Marcatti, MD6*, Anna Maria Cafro7*, Roberto Mina, MD8*, Renato Zambello, MD9*, Laura Paris, MD10*, Claudio Salvatore Cartia, MD1*, Gregorio Barilà11*, Cecilia Olivares12*, Alessandra Pompa13*, Rita Mazza, MD14*, Francesca Farina, MD6*, Martina Soldarini15*, Pietro Benvenuti, MD16*, Marica Lecci17*, Virginia Valeria Ferretti18* and Maria Teresa Petrucci, MD5

1Division of Hematology, IRCCS Fondazione Policlinico San Matteo Pavia, Pavia, Italy
2Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
3Division of Hematology, San Gerardo Hospital, Monza, Italy, Monza, Italy
4Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
5Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
6Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
7Hematology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Milan, Italy
8Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Milano, Italy
9Hematology and Clinical Immunology, Department of Medicine, Azienda Ospedaliera di Padova, Padova, Italy
10Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
11University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padova, Italy
12Division of Hematology, Ospedale di Circolo & Fondazione Macchi, University of Insubria , Varese , Italy, Varese, Italy
13Hematology and Bone Marrow Transplant Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
14Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milano, Italy
15Grande Ospedale Metropolitano Niguarda, Milan, Italy
16Division of Hematology, Fondazione IRCCS Policlinico San Matteo, pavia, Italy
17Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, torino, Italy
18Biometry and Clinical Epidemiology Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, Pavia, Italy

Samer Al Hadidi, MD, MSc, FACP1, Deepa Dongarwar, MS2*, Hamisu Salihu, MD PhD2*, Carolina Schinke, MD3, Sharmilan Thanendrarajan, MD3, Maurizio Zangari, MD, FACP3 and Frits van Rhee, MD PhD3

1Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock
2Baylor College of Medicine, Center of Excellence in Health Equity, Training and Research, Houston
3Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR

Qiufei Ma1*, Abigail Bailey2*, Neil Milloy2*, Jake Butcher2*, Ruben G.W Quek1* and Patrick Connor Johnson, MD3

1Health Economics and Outcomes Research, Regeneron Pharmaceuticals Inc., Tarrytown, NY
2Adelphi Real World, Bollington, United Kingdom
3Cancer Center, Massachusetts General Hospital, Boston, MA

Anna Narezkina, MD1*, Xiaoxiao Lu, PhD2*, Bruno Emond, MSc3*, Aurélie Côté-Sergent, MSc3*, Annalise Hilts, BA3*, Stephanie Liu, MPH4*, Marie-Hélène Lafeuille, MA3*, Patrick Lefebvre, MA3* and Qing Huang, PhD2*

1UC San Diego Health, San Diego, CA
2Janssen Scientific Affairs, LLC, Horsham, PA
3Analysis Group, Inc., Montreal, QC, Canada
4Analysis Group, Inc., Menlo Park, CA

Inna Gong, MD, PhD1, Abi Vijenthira, MD2, Stephen Betschel3*, Lisa K. Hicks, MD, MSc4,5 and Matthew C. Cheung, MD, MSc6,7

1Department of Medicine, University of Toronto, Toronto, ON, Canada
2Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
3St. Michael's Hospital, Toronto, ON, CAN
4Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada
5Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada
6Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
7ICES, Toronto, ON, Canada

Joshua Richter, MD1, Erin Singh, PhD2* and Megan S. Rice, ScD, MPH2*

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Sanofi, Cambridge, MA

Jakub Svoboda, MD1, Jonathon B. Cohen, MD, MS2, Chaitra S. Ujjani, MD3, David Andorsky, MD4*, Andre H. Goy, MD5*, Anita Kumar, MD6, Scott D Ramsey, MD, PhD7*, Mike Wallington8*, James M Eudicone9*, Rick Hermann10*, Victor Gonzalez, MA, MS11*, Michael Wang, MD12 and John M. Pagel, MD, PhD13

1Hospital of the University of Pennsylvania, Philadelphia, PA
2Emory University, Atlanta, GA
3University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
4Rocky Mountain Cancer Centers, Boulder, CO
5Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
6Department of Medicine, M, Short Hills, NJ
7Fred Hutchinson Cancer Research Center, Seattle, WA
8AstraZeneca, Cambridge, United Kingdom
9AstraZeneca, Wilmington, DE
10AstraZeneca, Gaithersburg, MD
11Lymphoma Research Foundation, New York, NY
12University of Texas MD Anderson Cancer Center, Houston, TX
13Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA

Lucia D Notardonato, MD1, Spencer S Langerman, BS2*, Jifang Zhou, MD, PhD, MPH3*, Gregory S Calip, PharmD, MPH, PhD4, Brian C-H Chiu, PhD2 and Ben A Derman, MD5

1Section of General Internal Medicine, University of Notre Dame, Chicago, IL
2Department of Public Health Sciences, University of Chicago, Chicago, IL
3School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China
4Department of Pharmacy Systems, Outcomes and Policy, University of Illinois At Chicago, Chicago, IL
5Section of Hematology/Oncology, University of Chicago, Chicago, IL

Louis Williams, MD1, Patrick Blaney, MS1,2*, Eileen M Boyle, MD, MSc3, Hussein Ghamlouch1*, Yubao Wang, PhD1*, Jinyoung Choi, PhD1*, Michael A Bauer, PhD4, Ariel Siegel1*, James Stoeckle, MD3*, Beatrice Razzo, MD5, Daniel Auclair, PhD6, David Kaminetzky, MD3*, Marc Braunstein, MD3, Benedetto Bruno, MD, PhD3*, Arnaldo A. Arbini, MD3*, Brian A Walker, PhD7, Faith E. Davies1* and Gareth J Morgan, MD, PhD1*

1NYU Langone Health, Myeloma Research Program, Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
2NYU Langone Medical Center, Applied Bioinformatics Laboratories, New York, NY
3Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY
4Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR
5Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New-York, NY
6Multiple Myeloma Research Foundation (MMRF), Norwalk, CT
7Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN

Rakesh Popat, MBBS, FRCPath, PhD1*, Zoe Craig, MSc2*, Faith E Davies, MD3, David Cairns, PhD4*, Catherine Olivier2*, J Anthony Child2*, Gareth J. Morgan, MD, PhD5, Gordon Cook, MB ChB, PhD2,6* and Graham H Jackson, MD, MA, MB BS, FRCP, FRCPath7

1University College London Hospitals, London, United Kingdom
2Leeds Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
3NYU Langone, Perlmutter Cancer Center, New York
4Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, ENG, United Kingdom
5Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY
6Leeds Cancer Centre, Leeds, United Kingdom
7Department of Haematology, Newcastle University, Newcastle upon Tyne, United Kingdom

Rema Ganapathy, MBBS DNB1*, Aswathy Ashok Beenakumari, PharmD2*, Syamaprasad Vinayakumar, PharmD2*, Remya Sudevan, MBBS MPH3*, Renjitha Bhaskaran, BSc2*, Shivali Ahlawat, MD4*, Geeta Vidyadharan, MD5*, Karthika K V, DM2*, Manoj Unni, MD DM6*, Ullas Mony7* and Neeraj Sidharthan, MD, DNB, DM8

1Department of Clinical Haematology, Amrita Institute of Medical Sciences, Kochi, India
2Amrita Institute of Medical Sciences, Kochi, India
3Department of Public Health, Amrita institute of Medical Sciences, Kochi, India
4Onquest laboratories, Delhi, India
5Amrita Institute of Medical Sciences, Kochi, KERALA, India
6Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences, Kochi, India
7Department of Biochemistry, Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental college and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Chennai, AL, India
8Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences , Amrita University, Kochi, Kerala, India

Annabel McMillan, MD1,2*, Supratik Basu3*, Kamaraj Karunanithi, MD4, Elizabeth A. Parkins, MD5*, Edward Yan Ming Lau, MD5*, Gordon Cook, MD6*, Christopher Parrish, MD7, Firas Al-Kaisi, MD8*, Guy Pratt, MD FRCP FRCPath9, Salim Shafeek, MD10, Stephen William Hart Jenkins, MD11*, Shivir Moosai, MD11*, Danish Memon, MD11*, Ceri A Bygrave, MD12*, Xenofon Papanikolaou, MD13,14*, Tara Maisel, MD15*, Sandra Hassan, MD15*, Gurvin Chander, MD16*, Bhuvan Kishore, MD16*, Farheen Karim, MD17*, Georgina Talbot, MD17*, Farooq A Wandroo, MD18, Dunsi Bolarinwa1*, Kwee Yong, MD, PhD19* and Rakesh Popat, MBBS, FRCPath, PhD20*

1University College London Hospitals NHS Foundation Trust, London, United Kingdom
2Whittington Health NHS Trust, London, United Kingdom
3The Royal Wolverhampton NHS Trust and University, West Midlands Research Consortium (WMRC), Wolverhampton, United Kingdom
4Royal Stoke University Hospital, WMRC, Stoke On Trent, United Kingdom
5Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom
6Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
7Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
8Royal Derby Hospital, Derby, ENG, United Kingdom
9Queen Elizabeth Hospital Birmingham, WMRC, Birmingham, United Kingdom
10Worcestershire Royal Hospital, WMRC, Birmingham, United Kingdom
11Russell Hall Hospital, WMRC, Dudley, United Kingdom
12University Hospital of Wales, Cardiff, United Kingdom
13The Lister Hospital, Stevenage, United Kingdom
14Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
15Queen's Hospital, Romford, United Kingdom
16University Hospitals Birmingham NHS Foundation Trust, WMRC, Birmingham, United Kingdom
17Royal Wolverhampton NHS Trust, WMRC, Wolverhampton, United Kingdom
18Sandwell & West Birmingham Hospitals NHS Trust, WMRC, West Bromwich, United Kingdom
19Department of Haematology, Univer, London, United Kingdom
20University College London Hospitals, NHS Foundation Trust, London, United Kingdom

Gregory S Calip, PharmD, MPH, PhD1,2, Mustafa S Ascha, PhD, MS2*, Xiaoliang Wang, PhD, MPH3*, Amy E Pierre, MSN, ANP-BC2*, Kathleen Maignan, MSN, NP2*, Niquelle B Wadé, PhD2*, Siyang Leng, MD, MS2, Erlene K Seymour, MD3, Brian C-H Chiu, PhD4, Karen Sweiss, PharmD5, Pritesh R Patel, MB, ChB6 and Natalia Neparidze, MD7

1Department of Pharmacy Systems, Outcomes and Policy, University of Illinois At Chicago, Chicago, IL
2Flatiron Health, New York, NY
3Flatiron Health Inc., New York, NY
4Department of Public Health Sciences, University of Chicago, Chicago, IL
5Department of Pharmacy Practice, University of Illinois, Hinsdale, IL
6Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
7Section of Hematology, Yale University, New Haven, CT

*signifies non-member of ASH